Literature DB >> 19870756

IMMUNIZATION OF EXPERIMENTAL ANIMALS WITH A SOLUBLE ANTIGEN EXTRACTED FROM PNEUMOCOCCI.

R J Dubos1.   

Abstract

Pneumococci killed by acetic acid at pH 4.2, then allowed to become Gram-negative at pH 7.0, under conditions such that no cellular disintegration takes place, release in solution small amounts of a substance which is precipitable by acetic acid, and soluble at neutral reaction. This soluble fraction injected into rabbits by the intravenous route causes the production of antibodies which afford definite protection to mice infected with virulent pneumococci of Types I, II, and III. Other types were not tried. White mice immunized with this soluble antigen exhibit some active immunity to virulent pneumococci, but the results have been very irregular so far. Soluble fractions, similar in properties and with apparently the same immunizing action, have been obtained from both virulent (S) and avirulent (R) cells of pneumococci.

Entities:  

Year:  1938        PMID: 19870756      PMCID: PMC2133631          DOI: 10.1084/jem.67.5.799

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  THE AUTOLYTIC SYSTEM OF PNEUMOCOCCI.

Authors:  R J Dubos
Journal:  J Exp Med       Date:  1937-05-31       Impact factor: 14.307

2.  THE EFFECT OF THE BACTERIOLYTIC ENZYME OF PNEUMOCOCCUS UPON THE ANTIGENICITY OF ENCAPSULATED PNEUMOCOCCI.

Authors:  R J Dubos
Journal:  J Exp Med       Date:  1937-06-30       Impact factor: 14.307

3.  THE EFFECT OF FORMALDEHYDE ON PNEUMOCOCCI.

Authors:  R J Dubos
Journal:  J Exp Med       Date:  1938-02-28       Impact factor: 14.307

  3 in total
  4 in total

1.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

2.  Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

Authors:  S C Szu; S Clarke; J B Robbins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

3.  Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

Authors:  L S McDaniel; J Yother; M Vijayakumar; L McGarry; W R Guild; D E Briles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

4.  Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.

Authors:  L S McDaniel; G Scott; J F Kearney; D E Briles
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.